Early Detection of Cognitive Decline: Executive Functioning Index R4Alz-pc Predicts Memory-Related Concerns in Community Adults
Authors:
- Eudokia EmmanouilidouEEEudokia Emmanouilidou
- Despina MoraitouDespina Moraitou
- Nikoleta FrantziNFNikoleta Frantzi
- Eleni PoptsiEPEleni Poptsi
- Emmanouil TsardouliasEmmanouil Tsardoulias
- Andreas L. SymeonidisAndreas L. Symeonidis
- Georgia PapantoniouGPGeorgia Papantoniou
- Maria SofologiMaria Sofologi
- Elvira MasouraEMElvira Masoura
- Glykeria TsentidouGTGlykeria Tsentidou
- Ioanna-Giannoula KatsouriIKIoanna-Giannoula Katsouri
- Magda TsolakiMagda Tsolaki
Open Access
- 26 August 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (17) , 2158
Abstract
Background/Objectives: Early identification of preclinical Alzheimer’s disease (AD) is critically important. This study investigates whether early cognitive decline in preclinical AD can be detected through the executive functioning index R4Alz-pc by predicting memory-related worry and negative affect. Methods: A sample of 105 cognitively healthy, community-dwelling older adults (M = 59.25 years) completed the Multifactorial Memory Questionnaire (MMQ) and the R4Alz-pc index battery. Results: Lower performance on the R4Alz-pc index was significantly associated with increased negative affect related to memory. Mediation analysis indicated that memory-related worry mediated the relationship between executive dysfunction and negative affect. Conclusions: This study highlights the importance of early, objective cognitive assessment using easy-to-administer and non-invasive tools like the R4Alz-pc, enabling timely detection and intervention for preclinical AD. Such methods may reduce reliance on costly biomarker-based diagnostics.Keywords
This publication has 68 references indexed in Scilit:
- Elevated amyloid‐ß and tau burden is associated with accelerated cognitive decline on a digital clock drawing test in preclinical ADAlzheimer's & Dementia, 2024
- Subjective cognitive decline: Memory complaints, cognitive awareness, and metacognitionAlzheimer's & Dementia, 2024
- Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s DiseaseBioDrugs, 2023
- A systematic review and network meta‐analysis of interventions for subjective cognitive declineAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2021
- Subjective cognitive decline: preclinical manifestation of Alzheimer’s diseaseNeurological Sciences, 2018
- Emerging β-Amyloid Pathology and Accelerated Cortical AtrophyJAMA Neurology, 2014
- The Influence of Exercise on Cognitive AbilitiesComprehensive Physiology, 2013
- PanVascular Medicine2013
- Dementia worry: a psychological examination of an unexplored phenomenonEuropean Journal of Ageing, 2012
- Amyloid‐beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B dataAnnals of Neurology, 2011